Ciclomed Llca Developmental Stage Pharmaceutical Company With A Collaborative Team Of Experts In Drug Development And Cancer Treatmentis Developing A Novel Drug Candidate Known As Ciclopirox Prodrug For Potential Treatment Of Bladder Cancerour Paradigm Changing Approach Springs From A Productive Public Private Partnership With The University Of Kansas Cancer Centerscientists At Ku Discovered Ciclopirox Prodrug And Demonstrated Its Potential In Preclinical Models As An Anticancer Agentciclopirox Prodrug For Injection Was Licensed To Ciclomed In 2015Our Team Is Collaborating With Experts Across The Country To Develop This Novel Drug For The Treatment Of Muscle Invasive And Non Muscle Invasive Bladder Cancer
